Equities

Envista Holdings Corp

Envista Holdings Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)22.18
  • Today's Change0.70 / 3.26%
  • Shares traded2.31m
  • 1 Year change-7.97%
  • Beta1.3123
Data delayed at least 15 minutes, as of Nov 25 2024 23:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.

  • Revenue in USD (TTM)2.50bn
  • Net income in USD-1.34bn
  • Incorporated2018
  • Employees12.80k
  • Location
    Envista Holdings Corp200 S. Kraemer Blvd., Bldg. EBREA 92821United StatesUSA
  • Phone+1 (714) 817-5418
  • Fax+1 (302) 655-5049
  • Websitehttps://envistaco.com/en
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
UFP Technologies Inc461.85m54.21m2.39bn3.09k44.487.2635.535.177.007.0059.6442.890.88964.186.15149,320.4010.449.6912.0010.9528.3126.3311.7410.141.4313.440.39190.0013.0816.007.5025.7114.08--
LeMaitre Vascular Inc213.03m41.32m2.43bn614.0059.227.3347.6411.401.821.829.4114.730.59921.117.59346,952.8011.629.0212.669.9368.3465.8319.4015.455.52--0.0040.4119.6912.8845.895.9618.9315.51
TransMedics Group Inc401.09m32.64m2.55bn584.0080.9912.1650.596.360.93890.938911.606.250.54393.565.32686,797.904.43-16.084.78-17.9559.3465.378.14-40.477.33--0.7078--158.5379.3630.92--225.12--
Enovis Corp2.00bn-121.38m2.61bn6.55k--0.782917.831.30-2.21-2.1736.4359.610.40231.595.91305,598.20-2.43-0.3569-2.66-0.4156.9648.19-6.03-1.061.120.98890.2876--9.22-4.89-40.29--11.91--
Quidelortho Corp2.82bn-1.87bn2.70bn7.10k--0.8465--0.9581-27.89-27.8942.0447.420.36742.627.84396,859.20-24.3411.34-27.7512.9147.6262.71-66.2520.930.81340.74190.44460.00-8.2141.83-101.84--45.87--
Warby Parker Inc742.53m-32.56m2.78bn2.14k--8.25245.173.75-0.2731-0.27316.202.801.225.70818.21346,975.20-5.37---6.78--55.3257.49-4.39-14.532.06--0.00--11.9819.6742.75------
LivaNova PLC1.24bn23.68m2.79bn2.90k120.492.1341.072.240.42590.425922.8124.130.51192.476.42428,185.900.9777-6.011.12-7.4267.7866.991.91-13.562.872.460.3234--12.890.8278120.34---1.64--
Inari Medical Inc574.50m-78.58m2.91bn1.30k--6.67--5.06-1.35-1.359.907.440.92211.597.46441,921.50-12.61-0.5941-15.24-0.669686.8289.06-13.68-0.62951.40--0.00--28.73135.4094.41--52.46--
Neogen Corp912.20m-23.53m3.25bn2.92k--1.0434.443.56-0.1086-0.10864.2114.470.20132.715.98312,718.20-0.51931.38-0.53461.4449.5648.23-2.584.312.791.030.22150.0012.3717.4158.81--50.02--
Envista Holdings Corp2.50bn-1.34bn3.70bn12.80k--1.20--1.48-7.77-7.7714.5117.860.41064.216.19195,570.30-21.931.94-25.272.3454.2057.65-53.425.291.773.130.31630.00-0.1012-2.04-142.10---4.22--
DENTSPLY SIRONA Inc3.90bn-413.00m3.73bn15.00k--1.50--0.9567-2.07-2.0718.9112.530.56412.945.91260,000.00-5.93-1.14-7.41-1.3252.1853.65-10.51-2.510.84443.210.471--1.10-0.107186.11---4.549.86
Guardant Health Inc692.26m-512.41m4.03bn1.78k------5.83-4.24-4.245.70-0.4880.4153.687.81389,126.50-30.72-22.26-35.19-24.5960.3164.62-74.02-97.075.85-8.041.06--25.4544.1426.76--0.2786--
ICU Medical Inc2.34bn-111.01m4.11bn14.00k--2.0136.121.76-4.57-4.5796.3183.760.53912.1613.94167,149.80-2.561.46-2.901.6532.8734.11-4.742.231.030.51580.43820.00-0.915410.0460.08---1.45--
Haemonetics Corporation1.36bn123.81m4.30bn3.66k35.534.9018.413.162.412.4126.4817.440.60011.877.02372,224.005.465.026.196.0754.0251.749.108.112.0927.430.58230.0012.016.231.8716.40-11.04--
Integer Holdings Corp1.68bn114.44m4.63bn10.50k42.582.8620.932.763.243.2247.8748.330.55944.935.14160,023.803.813.284.103.5327.0626.946.816.402.094.110.40280.0016.035.6238.719.3321.71--
Procept Biorobotics Corp199.84m-100.06m5.06bn626.00--20.23--25.32-1.95-1.953.894.630.50261.833.86319,238.00-25.16---28.58--57.39---50.07--5.07--0.1758--81.55---21.51------
Data as of Nov 25 2024. Currency figures normalised to Envista Holdings Corp's reporting currency: US Dollar USD

Institutional shareholders

57.25%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202416.98m9.88%
BlackRock Fund Advisorsas of 30 Sep 202415.08m8.77%
Atlanta Capital Management Co. LLCas of 30 Sep 202412.32m7.17%
Ariel Investments LLCas of 30 Sep 202411.36m6.61%
Harris Associates LPas of 30 Sep 202410.49m6.10%
American Century Investment Management, Inc.as of 30 Sep 20247.99m4.65%
Nuance Investments LLCas of 30 Sep 20247.35m4.27%
Citadel Advisors LLCas of 30 Sep 20246.11m3.55%
SSgA Funds Management, Inc.as of 30 Sep 20245.43m3.16%
Dimensional Fund Advisors LPas of 30 Sep 20245.33m3.10%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.